N. Tepper

K. Curtis, D. Jamieson, L. Zapata, 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs.

K. Curtis, L. Zapata, A. Marcell, 2014, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.

Madison, J. W. Stephens, Stephen R. Spriggs, 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.

K. Curtis, D. Jamieson, L. Zapata, 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

U S. medical eligibility criteria for contraceptive use, 2010 : adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition

K. Curtis, P. Marchbanks, N. Tepper, 2010 .

Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010–May 2016

J. Cragan, Paige W. Lewis, M. Cano, 2017, Drug Safety.

Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women.

S. Rasmussen, J. Tokars, D. Kissin, 2012, American journal of obstetrics and gynecology.

Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population

K. Curtis, D. Jamieson, L. Zapata, 2015, Obstetrics and Gynecology.

A systematic review and meta‐analysis of venous thrombosis risk among users of combined oral contraception

R. Chou, K. Curtis, R. Fu, 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Rapid human immunodeficiency virus testing on labor and delivery.

B. Branson, S. Farr, D. Jamieson, 2008, Obstetrics and gynecology.

Postpartum intrauterine device insertion and postpartum tubal sterilization in the United States.

K. Curtis, S. Cox, D. Jamieson, 2012, American journal of obstetrics and gynecology.

Marketing of breast-milk substitutes: National implementation of the international code. Status report 2016.

Hannah L Ratcliffe, G. Dinant, S. Zodpey, 2016 .

Hormonal Contraceptive Use Among Women of Older Reproductive Age: Considering Risks and Benefits.

K. Curtis, P. Marchbanks, S. Folger, 2018, Journal of women's health.

Incidence and Risk Factors

Michael Monsour, K. Curtis, Y. Toiyama, 2016 .

Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and Infants

C. Olson, Andrea J. Sharma, S. Ellington, 2023, Obstetrics and Gynecology Clinics of North America.

Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.

K. Curtis, D. Jamieson, P. Marchbanks, 2012, MMWR. Morbidity and mortality weekly report.

Developing Federal Clinical Care Recommendations for Women.

K. Curtis, E. Godfrey, N. Tepper, 2015, American journal of preventive medicine.

Update to CDC’s U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection

K. Curtis, S. Cox, M. Whiteman, 2017, MMWR. Morbidity and mortality weekly report.

Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recommendations for the Use of Contraception Among Women at High Risk for HIV Infection

K. Curtis, S. Cox, M. Whiteman, 2020, MMWR. Morbidity and mortality weekly report.

Pharmacists' knowledge, attitudes, and practices regarding influenza vaccination and treatment of pregnant women.

Siobhan M. Dolan, S. Rasmussen, S. Cox, 2012, Journal of the American Pharmacists Association : JAPhA.

Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak--Puerto Rico, 2016.

Meghan T. Frey, S. Rasmussen, N. Pesik, 2016, MMWR. Morbidity and mortality weekly report.

Expulsion of intrauterine devices after postpartum placement by timing of placement, delivery type, and IUD type: a systematic review and meta-analysis.

K. Curtis, D. Jamieson, P. Marchbanks, 2020, American journal of obstetrics and gynecology.

Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis.

K. Curtis, D. Jamieson, P. Marchbanks, 2018, Obstetrics and gynecology.

Removing medical barriers to contraception - evidence-based recommendations from the Centers for Disease Control and Prevention, 2016.

K. Curtis, M. Whiteman, Tara C. Jatlaoui, 2016, Contraception.

Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya

J. Baeten, R. Heffron, G. Doncel, 2022, Scientific Reports.

Putting risk into perspective: The US medical eligibility criteria for contraceptive use

K. Curtis, P. Marchbanks, N. Tepper, 2011, Reviews in Endocrine and Metabolic Disorders.

Singleton Preterm Birth: Risk Factors and Association with Assisted Reproductive Technology

S. Farr, M. Macaluso, D. Jamieson, 2012, Maternal and Child Health Journal.

Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum.

K. Curtis, S. Boulet, M. Whiteman, 2019, Obstetrics and gynecology.

Safety of contraceptive use among women with congenital heart disease: A systematic review.

S. Farr, Ginnie Abarbanell, N. Tepper, 2019, Congenital heart disease.

Health Care Provider Attitudes Toward Safety of Selected Hormonal Contraceptives in Breastfeeding Women

L. Zapata, N. Tepper, Allison Mayhew, 2019, Maternal and Child Health Journal.

Research gaps from evidence-based contraception guidance: the US Medical Eligibility Criteria for Contraceptive Use, 2016, and the US Selected Practice Recommendations for Contraceptive Use, 2016.

K. Curtis, S. Folger, Tara C. Jatlaoui, 2016, Contraception.

Using a Checklist to Assess Pregnancy in Teenagers and Young Women

K. Curtis, P. Marchbanks, M. Whiteman, 2014, Obstetrics and gynecology.

Use of a checklist to rule out pregnancy: a systematic review.

K. Curtis, P. Marchbanks, N. Tepper, 2013, Contraception.

Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review.

K. Curtis, Maria W. Steenland, P. Marchbanks, 2013, Contraception.

Adverse Events following Administration to Pregnant Women of Influenza A (H1N1) 2009 Monovalent Vaccine reported to the Vaccine Adverse Event Reporting System (VAERS).

Kimp Walton, F. Destefano, D. Kissin, 2019 .

Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy

L. Grohskopf, K. Broder, C. Vellozzi, 2012, Expert review of vaccines.

Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study.

Mardge H. Cohen, M. Webber, S. Farr, 2009, American journal of obstetrics and gynecology.

Case Series of Thrombosis with Thrombocytopenia Syndrome following COVID-19 vaccination--United States, December 2020-August 2021

T. Ortel, E. Woo, E. Walter, 2021, medRxiv.

Healthcare Provider Attitudes of Safety of Intrauterine Devices in the Postpartum Period.

K. Curtis, D. Jamieson, L. Zapata, 2017, Journal of women's health.

Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink.

J. Nelson, J. Glanz, A. Naleway, 2020, Obstetrics and gynecology.

Assisted reproductive technology and trends in low birthweight--Massachusetts, 1997-2004.

S. Farr, M. Macaluso, D. Jamieson, 2009, MMWR. Morbidity and mortality weekly report.

Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials

R. Chaisson, T. Sterling, R. Belknap, 2018, Annals of the American Thoracic Society.

Guidance on medical eligibility criteria for contraceptive use: identification of research gaps.

K. Curtis, P. Marchbanks, S. Folger, 2010, Contraception.

Intrauterine contraceptive insertion postabortion: a systematic review.

K. Curtis, Maria W. Steenland, N. Kapp, 2011, Contraception.

Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015.

J. Cragan, Y. Zheteyeva, Paige W. Lewis, 2016, Vaccine.

Multijurisdictional Analyses of Birth Defects: Considering the Common Data Model Approach.

S. Gilboa, J. Reefhuis, N. Tepper, 2022, Pediatrics.

Contraceptive Use: Guidelines and Effectiveness

K. Curtis, P. Marchbanks, N. Tepper, 2011 .

Reproductive Health of Women with Congenital Heart Defects.

S. Farr, J. Reefhuis, M. Oster, 2023, Journal of women's health.

Contraceptive availability during an emergency response in the United States.

K. Curtis, M. Zotti, W. Barfield, 2013, Journal of women's health.

FDA Public Meeting Report on “Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications”

R. S. Day, D. Strauss, Lei Zhang, 2018, Journal of clinical pharmacology.

U.S. Selected Practice Recommendations for Contraceptive Use, 2016.

K. Curtis, D. Jamieson, L. Zapata, 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Blood pressure measurement prior to initiating hormonal contraception: a systematic review.

K. Curtis, Maria W. Steenland, P. Marchbanks, 2013, Contraception.

U.S. selected practice recommendations for contraceptive use, 2013.

K. Curtis, P. Marchbanks, N. Tepper, 2014, Journal of women's health.

Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study.

Mardge H. Cohen, M. Webber, S. Farr, 2009, American journal of obstetrics and gynecology.

U.S. Medical Eligibility Criteria for Contraceptive Use, 2024

N. Verma, M. Whiteman, N. Tepper, 2024, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

U.S. medical eligibility criteria for contraceptive use, 2010.

P. Marchbanks, N. Tepper, Kathryn M. Curtis, 2011, Journal of women's health.

U.S. Selected Practice Recommendations for Contraceptive Use, 2024

N. Verma, M. Whiteman, N. Tepper, 2024, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Removing barriers to contraception through use of criteria to assess pregnancy risk.

K. Curtis, M. Whiteman, Tara C. Jatlaoui, 2017, Contraception.

Intimate Partner Violence around the Time of Pregnancy and Postpartum Contraceptive Use.

I. Ahluwalia, L. Zapata, N. Tepper, 2020, Women's health issues : official publication of the Jacobs Institute of Women's Health.